These data suggest vaping poses potential threats to the development of the brain and organs, with teenagers being a predominant target due to surges in use.
Dr Theodore Leng discusses what the future may hold for patients with diabetic macular edema.
Expert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.
Experts outline biomarkers to measure asthma, highlighting eosinophil count and fractional exhaled nitric oxide levels.
Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, and Madeline King, PharmD, BCIDP, provide insight on vaccine hesitancy among patients and the importance of increasing vaccine uptake to protect against SARS-CoV-2.
Closing thoughts regarding a discussion on improving the management of patients with treatment-resistant depression using newer treatment approaches in a more standardized fashion.
Experts in pediatric hepatology share advice for the optimal management of Alagille syndrome.
Clinical pearls regarding the management of patients with atopic dermatitis with newer treatment approaches as the field continues to evolve.
Experts in pediatric hepatology share advice for the optimal management of Alagille syndrome.
A panel of expert cardiologists share their concluding thoughts on management of polyvascular disease in clinical practice.
Drs Keegan and Cameron discuss patient-specific considerations for selecting optimal atopic dermatitis treatment strategies.
Dermatological experts discuss challenges that are associated with the use of standard and emerging treatments in special patient population.
AHN's AI-ILD clinic provides collaborative care, uniting pulmonology and rheumatology specialists for efficient treatment of ILD.
Eiran Gorodeski, MD, MPH, Parag Goyal, MD, MSc, and James Fang, MD, discuss the HFSA's recent scientific statement on the prevalence and impact of cognitive impairment on the management of heart failure.
Iltefat Hamzavi, MD, explores key areas of patient communication that may shape adherence and outcomes in patients with vitiligo.
Experts in dermatology share advice on helping fellow physicians stay apprised of the advances in AD and treat their patients more effectively.
A history of bariatric surgery was associated with up to 50% reduced risk of PDAC among a national cohort.
Steve Harvey, MD, discusses the challenges of defining treatment resistant depression and provides and overview of treatment options.
Clinical pearls regarding the management of patients with atopic dermatitis with newer treatment approaches as the field continues to evolve.
Concluding their discussion on sickle cell disease management, expert panelists share key unmet needs and hopes for the future.
A history of bariatric surgery was associated with up to 50% reduced risk of PDAC among a national cohort.
Mark Barakat, MD, reviews the best practices for patient communication and shared decision making.
Veeral Sheth, MD, MBA discusses the 3 improvements needed for the future of treating patients with geographic atrophy.
Iltefat Hamzavi, MD, explores key areas of patient communication that may shape adherence and outcomes in patients with vitiligo.
Andrew Wang, MD; James Januzzi, MD; Michelle M. Kittleson, MD, PhD; and Milind Desai, MD, MBA, share a look into the future of oHCM treatment.
Experts in gastroenterology discuss treatment selection in special situations of CD, such as age, women considering pregnancy, and extra-intestinal manifestations.